FIGURE 2 Enhanced oxidative stability in MF-Prepared emulsions
changes in AV. AV (A) and POV(B) of KO emulsion prepared by HPH / MF
during an accelerated storage period. Different letters above the
columns represent significant differences at p < 0.05.
Bars represent standard deviations (n = 3)
FIGURE 3 Evolution of functional compounds during accelerated
storage . TAG decrease rate (A), PL decrease rate (B), EPA
decrease rate (C), DHA decrease rate (D), astaxanthin decrease rate (E),
and PC content (F) of KO emulsion prepared by HPH / MF during
accelerated storage. Different letters above the columns represent
significant differences at p < 0.05. Bars represent
standard deviations (n = 3)
FIGURE 4 Changes in particle size and Zeta-Potential duringIn Vitro digestion. Particle size distribution (A) and
zeta-potentials (B) of emulsions prepared using HPH / MF after exposure
to different stages of simulated gastrointestinal tract (GIT), *p < 0.05